IRIS PubliCatt

Zocco, Maria Assunta
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 5.582
NA - Nord America 4.148
AS - Asia 1.675
AF - Africa 60
OC - Oceania 52
SA - Sud America 21
Continente sconosciuto - Info sul continente non disponibili 20
Totale 11.558
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.081
DE - Germania 2.342
SE - Svezia 1.031
IT - Italia 701
CN - Cina 660
SG - Singapore 436
UA - Ucraina 375
IE - Irlanda 242
GB - Regno Unito 226
FR - Francia 218
ID - Indonesia 158
IN - India 128
FI - Finlandia 127
RU - Federazione Russa 102
TR - Turchia 88
CA - Canada 59
BE - Belgio 51
AU - Australia 49
PL - Polonia 39
IR - Iran 34
CH - Svizzera 26
HK - Hong Kong 23
SA - Arabia Saudita 21
JP - Giappone 19
NL - Olanda 19
CI - Costa d'Avorio 17
EU - Europa 16
RO - Romania 16
CZ - Repubblica Ceca 14
PH - Filippine 13
IL - Israele 12
TW - Taiwan 12
PK - Pakistan 11
BR - Brasile 10
MY - Malesia 10
EG - Egitto 9
CL - Cile 8
LT - Lituania 8
VN - Vietnam 8
AE - Emirati Arabi Uniti 7
ES - Italia 7
GR - Grecia 7
KR - Corea 7
TN - Tunisia 7
AT - Austria 6
BD - Bangladesh 6
SD - Sudan 6
TH - Thailandia 5
ZA - Sudafrica 5
ML - Mali 4
A1 - Anonimo 3
CO - Colombia 3
JO - Giordania 3
MA - Marocco 3
MK - Macedonia 3
NG - Nigeria 3
NO - Norvegia 3
NP - Nepal 3
NZ - Nuova Zelanda 3
PA - Panama 3
PT - Portogallo 3
RS - Serbia 3
AL - Albania 2
CM - Camerun 2
EE - Estonia 2
HR - Croazia 2
HU - Ungheria 2
IQ - Iraq 2
KE - Kenya 2
MD - Moldavia 2
MG - Madagascar 2
MO - Macao, regione amministrativa speciale della Cina 2
SK - Slovacchia (Repubblica Slovacca) 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BH - Bahrain 1
CY - Cipro 1
DO - Repubblica Dominicana 1
GL - Groenlandia 1
KH - Cambogia 1
KW - Kuwait 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MM - Myanmar 1
MX - Messico 1
PR - Porto Rico 1
TT - Trinidad e Tobago 1
Totale 11.558
Salva come PNG Salva come JPEG
Città #
Chandler 910
Singapore 346
Ashburn 320
Dublin 239
Jacksonville 190
San Mateo 190
New York 187
Ann Arbor 167
Rome 159
Jakarta 157
Nürnberg 157
Nanjing 125
Cattolica 120
Marseille 113
Wilmington 107
Chicago 102
Munich 93
Milan 91
Boston 89
Beijing 85
Woodbridge 79
Izmir 78
Moscow 73
Princeton 73
Dearborn 68
Bremen 64
Seattle 61
Boardman 60
Helsinki 53
Brussels 45
Nanchang 45
Los Angeles 44
Houston 40
Redwood City 39
Hangzhou 36
Fairfield 35
Zhengzhou 34
Tianjin 30
Hebei 28
Lawrence 28
Kraków 27
Lancaster 26
Norwalk 25
Pune 24
University Park 24
Augusta 23
Leawood 22
Mountain View 21
Shenyang 20
Changsha 19
Fremont 19
Toronto 19
Guangzhou 18
London 18
Abidjan 17
Jiaxing 17
Hong Kong 16
Zurich 15
Kunming 14
Santa Clara 13
Shanghai 13
Dammam 11
Frankfurt am Main 11
Jinan 10
Kish 10
Ottawa 10
Québec 10
Simi Valley 10
Taipei 10
Andover 9
Detroit 9
Sydney 9
Warsaw 9
Amsterdam 8
Campagna 8
Ningbo 8
Nuremberg 8
Oggiono 8
Paris 8
San Jose 8
Al Qatif 7
Boydton 7
Brno 7
Edinburgh 7
Las Vegas 7
Provo 7
Redmond 7
Tokyo 7
Washington 7
Bern 6
Botosani 6
Naples 6
San Diego 6
Cairo 5
Cambridge 5
Changchun 5
Chengdu 5
Düsseldorf 5
Esslingen am Neckar 5
Indiana 5
Totale 5.666
Salva come PNG Salva come JPEG
Nome #
Post-COVID-19 global health strategies: the need for an interdisciplinary approach 431
From small nodule to overt HCC: a multistep process of carcinogenesis as seen during surveillance 280
Portal vein thrombosis: insight into physiopathology, diagnosis, and treatment 277
13C-methionine breath tests for mitochondrial liver function assessment. 203
13C-breath tests in the study of microsomal liver function 193
The role of small intestinal bacterial overgrowth in Parkinson's disease 182
Improvement of mortality rate and decrease in histologic hepatic injury after human cord blood stem cell infusion in a murine model of hepatotoxicity. 175
-High prevalence of celiac disease in patients with lactose intolerance 173
-Hepatic steatosis and vascular disease 168
-Catholic university experience with molecular adsorbent recycling system in patients with severe liver failure 166
-Improvement of mortality rate and decrease in histologic hepatic injury after human cord blood stem cell infusion in a murine model of hepatotoxicity 157
134C-breath tests in the study of mitochondrial liver function 153
Gut microbiota compositional and functional fingerprint in patients with alcohol use disorder and alcohol-associated liver disease 149
A) Bacillus clausii therapy to reduce side-effects of anti-Helicobacter pylori treatment: randomized, double-blind, placebo controlled trial. 144
Early prediction of response to sorafenib in patients with advanced hepatocellular carcinoma: the role of dynamic contrast enhanced ultrasound 144
13C-breath tests in the study of microsomial liver function 139
Effect of rifaximin on gut microbiota composition in advanced liver disease and its complications 134
Thrombotic risk factors in patients with liver cirrhosis: correlation with MELD scoring system and portal vein thrombosis development 131
-Moxifloxacin-based strategies for first-line treatment of Helicobacter pylori infection. 129
-How does human stem cell therapy influence gene expression after liver injury? Microarray evaluation on a rat model 129
Levofloxacin-based triple therapy in first-line treatment for Helicobacter pylori eradication 129
-No evidence of hematopoietic stem cell mobilization in patients submitted to hepatectomy or in patients with acute on chronic liver failure 129
Safety and efficacy profile of G-CSF therapy in patients with acute on chronic liver failure 128
Something more to say about calcium homeostasis: the role of vitamin K2 in vascular calcification and osteoporosis 126
Early prediction of response to Sorafenib in patients with advanced hepatocellular carcinoma: the role of dynamic contrast enhanced ultrasound 124
Post-COVID-19 global health strategies: the need for an interdisciplinary approach 124
-Human cordonal stem cell intraperitoneal injection can represent a rescue therapy after an acute hepatic damage in immunocompetent rats 123
13C-methionine breath tests for mitochondrial liver function assessment 123
Levofloxacin-based triple therapy vs. quadruple therapy in second-line Helicobacter pylori treatment: a randomized trial. 120
Treatment of H. pylori infection: a review. 120
Human cordonal stem cell intraperitoneal injection can represent a rescue therapy after an acute hepatic damage in immunocompetent rats. 120
CD133+ stem cell mobilization after partial hepatectomy depends on resection extent and underlying disease 116
Beta-lactamase inhibitor enhances Helicobacter pylori eradication rate. 114
-Bacillus clausii effect on gene expression pattern in small bowel mucosa using DNA microarray analysis 114
. High prevalence of Cag-A positive H. pylori strains in ischemic stroke: a primary care multicenter study. 114
13C-breath tests in the study of mitochondrial liver function 112
Diagnosis of bowel diseases: the role of imaging and ultrasonography 112
Delta13CO2 excretion and expression of dyspeptic symptoms in patients evaluated for Helicobacter pylori infection by [13C] urea breath test 111
-The decrease in cytokine concentration during albumin dialysis correlates with the prognosis of patients with acute on chronic liver failure 109
Prevention and treatment of hepatic encephalopathy: focusing on gut microbiota 108
Levofloxacin based regimens for the eradication of Helicobacter pylori 107
-Improvement of mitochondrial function evaluated by ketoisocaproic acid breath test in patients with HCV infection undergoing albumin dialysis 105
Portal vein tumor thrombosis revascularization during sorafenib treatment for hepatocellular carcinoma 102
Something more to say about calcium homeostasis: the role of vitamin K2 in vascular calcification and osteoporosis 101
Transarterial chemoembolization with degradable starch microspheres (DSM-TACE): an alternative option for advanced HCC patients? Preliminary results 101
. Quick test: a new test for the diagnosis of duodenal hypolactasia. 99
Transdifferentiation of stem cells in pancreatic cells: state of the art 99
-From stem cell to solid organ. Bone marrow, peripheral blood or umbilical cord blood as favorable source? 95
Liquid melevodopa versus standard levodopa in patients with Parkinson disease and small intestinal bacterial overgrowth 95
-Can 13C urea breath test predict resistance to therapy in Helicobacter pylori infection? 94
TACE with degradable starch microspheres (DSM-TACE) as second-line treatment in HCC patients dismissing or ineligible for sorafenib 93
Rescue therapy by portal infusion of autologous stem cells in a case of drug-induced hepatitis 92
Liver transplantation in patients with alcoholic liver disease: A retrospective study 92
Regression of lactose malabsorption in coeliac patients after receiving a gluten-free diet. 89
How does human stem cell therapy influence gene expression after liver injury? Microarray evaluation on a rat model 87
Different Antibiotic No Culture Eradicating (DANCE) strategy: An easy way to manage H. pylori eradication 87
Fatigue in Covid-19 survivors: The potential impact of a nutritional supplement on muscle strength and function 86
Mono, dual and triple moxifloxacin-based therapies for Helicobacter pylori eradication 86
High Prevalence and Gender-Related Differences of Gastrointestinal Manifestations in a Cohort of DM1 Patients: A Perspective, Cross-Sectional Study 86
Something more to say about calcium homeostasis: the role of vitamin K2 in vascular calcification and osteoporosis. 84
Saccharomyces boulardii and Antibiotic-Associated Diarrhea: Effectiveness of Prophylactic Use 83
Fatigue in Covid-19 survivors: The potential impact of a nutritional supplement on muscle strength and function 82
Rescue therapy by portal infusion of autologous stem cells in a case of drug-induced hepatitis. 82
Bacteroides thetaiotaomicron in the gut: molecular aspects of their interaction. 82
Anticoagulants in cirrhotic patients: controversies and certainties in PVT management 80
Liver Stiffness in Pediatric Patients with Fatty Liver Disease: Diagnostic Accuracy and Reproducibility of Shear-Wave Elastography 78
Contrast-enhanced ultrasound in the short-term evaluation of hepatocellular carcinoma after locoregional treatment 78
Is there a role for anticoagulants in portal vein thrombosis management in cirrhotic patients? 77
Clinical characteristics of metabolic associated fatty liver disease (MAFLD) in subjects with myotonic dystrophy type 1 (DM1) 76
What we should know about portal vein thrombosis in cirrhotic patients: A changing perspective 75
Review article: breath testing for human liver function assessment. 75
Usefulness of contrast enhanced ultrasound in monitoring therapeutic response after hepatocellular carcinoma treatment 75
Functional and metabolic disorders in celiac disease: new implications for nutritional treatment 72
Subclinical atherosclerosis is linked to small intestinal bacterial overgrowth via vitamin K2-dependent mechanisms 71
Residual respiratory impairment after COVID-19 pneumonia 71
Reverse time-dependent effect of alphafetoprotein and disease control on survival of patients with Barcelona Clinic Liver Cancer stage C hepatocellular carcinoma 70
Contrast ultrasound LI-RADS LR-5 identifies hepatocellular carcinoma in cirrhosis in a multicenter restropective study of 1,006 nodules 70
Liver Resection versus Radiofrequency Ablation plus Transcatheter Arterial Chemoembolization in Cirrhotic Patients with Solitary Large Hepatocellular Carcinoma 68
A) Quantitative evaluation of liver function by the methionine and aminopyrine breath tests in the early stages of liver transplantation 66
Correlation Between QElaXto Techniques and Supersonic Imagine for Liver Stiffness Quantification in Chronic Liver Disease 66
Psychological Distress After Covid-19 Recovery: Reciprocal Effects With Temperament and Emotional Dysregulation. An Exploratory Study of Patients Over 60 Years of Age Assessed in a Post-acute Care Service 64
Madelung's disease and acute alcoholic hepatitis: case report and review of literature 63
Clinical use of albumin in hepatology. 62
A novel ultrasound-based vascular calcification score (CALCS) to detect subclinical atherosclerosis 62
TACE with degradable starch microspheres (DSM-TACE) as second-line treatment in HCC patients dismissing or ineligible for sorafenib 62
Contrast-enhanced ultrasound patterns of hepatocellular adenoma: an Italian multicenter experience 60
Probiotics and small bowel mucosa: Molecular aspects of their interactions 59
Minimal Hepatic Encephalopathy is Associated with Increased Cerebral Vascular Resistance. A Transcranial Doppler Ultrasound Study 59
Usefulness of contrast-enhanced ultrasound (CEUS) in Inflammatory Bowel Disease (IBD) 58
Bowel contrast-enhanced ultrasound perfusion imaging in the evaluation of Crohn's disease patients undergoing anti-TNFα therapy 57
-Helicobacter pylori and extragastric diseases--other Helicobacters 56
Idiopathic chronic constipation: pathophysiology, diagnosis and treatment 56
Portal vein thrombosis and liver transplantation: Implications for waiting list period, surgical approach, early and late follow-up. 56
Future of liver disease in the era of direct acting antivirals for the treatment of hepatitis C 55
Seroprevalence of anti-SARS-CoV-2 IgG antibodies in children with household exposure to adults with COVID-19: Preliminary findings 55
The role of elastography in non-Alcoholic fatty liver disease 52
Portal vein thrombosis in cirrhosis: Why a well-known complication is still matter of debate 51
Eubiotic properties of rifaximin: Disruption of the traditional concepts in gut microbiota modulation 46
A new ultrasound score for the assessment and follow-up of chronic pancreatitis: The ‘Gemelli USCP score’ 44
Bacterial translocation in patients with liver cirrhosis: physiology, clinical consequences, and practical implications 42
Totale 10.529
Salva come PNG Salva come JPEG
Categoria #
all - tutte 49.273
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 49.273
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020852 0 0 0 0 110 96 144 58 92 111 154 87
2020/20211.136 89 86 35 82 117 61 101 31 128 182 196 28
2021/20221.176 86 97 36 95 94 35 25 190 34 64 185 235
2022/20233.146 349 349 254 523 270 398 187 215 309 122 121 49
2023/20241.533 79 356 60 44 66 262 89 48 30 118 168 213
2024/2025776 68 80 276 137 215 0 0 0 0 0 0 0
Totale 11.714